InflammaSense

One liner: Wouldn't it be amazing to recruit reliable responder patients for your clinical trial, dramatically reducing costs and minimizing the risk of trial failure? The InflammaSense mental health solution stands out for its ability to predict mental health severity at a granularity not possible until now. The blended mental health stratification approach including: electronic record (EMR) algorithmic modeling and novel Autonomic Neural and Point of Care Molecular Biomarker scans (5 min), radically reduces non-responder rates (up to 80%) and mental health disorder clinical trial costs ($5Mil-$2Bill/trial). Proof of Concept: InflammaSense has built and deployed proof of concept EMR model (Trained 13.4 Mill) and wearable patch system for fast mental health severity prediction in less than < 5 min. The system has been tested in 50 subjects and has shown promising results (sensitivity and specificity >90%) Seamlessly Integrated into Current Vital Sign Monitoring Comfortable for Patients 24/7 Continuous Monitoring and Support for Your Team PRECISE ENGINEERING Immediately transmit inflammation based diseases severity for clinical trials. InflammaSense exists at the cutting edge of technology. Our novel and purpose-made machine-learning algorithms drive high quality and reproducible data analyses and the generation mental health severity stratification and inflammation associated with disease. A clinical decision support tool you can trust Backed by peer-reviewed research and clinical trials FULL INTEGRATION FHR-Enabled Epic App Orchard and Cerner App Friendly All Workflows Can Be Completed From Within Your EHR